Last reviewed · How we verify
NCT04406155
Bowel Preparation Before 3D Rectal Water Contrast Transvaginal Ultrasonography for Rectosigmoid Endometriosis
trial testing 3D-RWC-TVS with bowel preparation in Endometriosis, Rectum in 60 participants. Completed in 1 January 2020.
1 December 2019
Quick facts
| Lead sponsor | Piazza della Vittoria 14 Studio Medico - Ginecologia e Ostetricia |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 1 January 2018 |
| Primary completion | 1 December 2019 |
| Estimated completion | 1 January 2020 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- 3D-RWC-TVS with bowel preparation
- 3D-RWC-TVS without bowel preparation
Conditions studied
- Endometriosis, Rectum — all drugs for Endometriosis, Rectum →
Sponsor
Piazza della Vittoria 14 Studio Medico - Ginecologia e Ostetricia
Who can join
18 and older, female only, with Endometriosis, Rectum. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Three-dimensional (3D) rendering may be employed during transvaginal rectal water-contrast transvaginal ultrasonography (RWC-TVS) for detecting the presence and describe the characteristics of rectosigmoid endometriosis. This study aims to evaluate the impact of bowel preparation on the diagnostic parameters of 3D-RWC-TVS in women with suspicion of rectosigmoid endometriosis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04406155
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Endometriosis, Rectum
Currently open trials in the same condition.
- NCT04204707 — Patient Reported Outcomes After Surgery for Rectal Endometriosis · active not recruiting
Other Piazza della Vittoria 14 Studio Medico - Ginecologia e Ostetricia trials
Trials by the same sponsor.
- NCT05909410 — Perception About Benefits and Risks Related to Combined Hormonal Contraceptives Use in Patients With Lynch Syndrome · unknown
- NCT05291624 — Ultrasonographic and Surgical Assessment of Endometriosis by AAGL 2021 Endometriosis Classification · unknown
- NCT04936386 — Knowledge and Perspective of Healthcare Professionals About Female Genital Mutation · completed
- NCT04395755 — Impact of COVID-19 on Psychological Status in Case of IVF Interrupted or Postponed · completed
- NCT04338945 — Impact of Pandemic COVID-19 on Surgical Specialities Residents in Italy · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04406155 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Piazza della Vittoria 14 Studio Medico - Ginecologia e Ostetricia
- Last refreshed: 27 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04406155.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing